BNO - Healthy Investment eConference - Dr Deborah Rathjen, CEO and Managing Director
Wed, 1 Jul 2009 11:00am
Dr Deborah Rathjen
Fri, 11 Nov 2011 9:45am
Dr Deborah Rathjen, Managing Director, CEO
Dr Deborah Rathjen
Fri, 4 Nov 2011 11:25am
Deborah Rathjen, Managing Director & CEO
Dr Deborah Rathjen
Fri, 12 Aug 2011 11:30am
Dr Deborah Rathjen, Managing Director
Dr Deborah Rathjen
Thu, 13 May 2010 10:30am
BNC210 is being developed for the treatment of anxiety and depression
Icon_lastIcon_nextIcon_previousIcon_first